BioSpace News Archive

Business

Illumina CEO DeSouza Steps Down Amid Activist Attack, Anti-Trust Battle

Francis deSouza resigned from Illumina’s helm after strong campaigning from activist investor Carl Icahn and the ongoing regulatory roadblocks facing the company’s acquisition of GRAIL.

June 12, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Novartis Boosts Kidney Business with $3.2B Chinook Buy

The company is paying $3.2 billion upfront in cash for Chinook’s two immunoglobulin A nephropathy candidates, atrasentan and zigakibart, which will complement its own IgAN hopeful iptacopan.

June 12, 2023
·
2 min read
·
Tristan Manalac
Policy

Chamber of Commerce Seeks to Halt Drug Price Negotiation

In its latest legal challenge to the Inflation Reduction Act, the U.S. Chamber of Commerce has appealed to a federal court to stop drug price negotiations until ongoing litigation plays out.

June 12, 2023
·
5 min read
·
Lisa Munger
Business

Catalent Finally Reports Earnings: Despite Losses, Revenue Beat Projections

After multiple delays, the contract manufacturer presents its earnings report for the third quarter of fiscal 2023, bumping its stock by more than 10%.

June 12, 2023
·
2 min read
·
Alejandra Manjarrez
Policy

Pharma Companies, Pharmacies Agree to Pay $19B in Opioid Settlement

More than 3,000 state and local governments will receive nearly $19 billion in payments from drugmakers and pharmacy chains in the most recent round of opioid settlements.

June 12, 2023
·
2 min read
·
Tristan Manalac
Employer Resources

Opinion: Manage a Team? Here’s How to Keep Your Top Performers

Scott Rivers, president and managing partner of an executive search and talent branding firm, weighs in on what managers can do to keep top talent.

June 12, 2023
·
4 min read
·
Scott Rivers
Biotech Beach

Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use

Applied BioCode now offers Fungal Panel on the BioCode® MDx-3000 system for research use only.

June 12, 2023
·
4 min read
Pharm Country

Merck to Present Data for Efinopegdutide (MK-6024), an Investigational GLP-1/Glucagon Receptor Co-agonist, in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) at EASL 2023

Merck, known as MSD outside of the United States and Canada, announced that new findings for efinopegdutide, an investigational GLP-1/glucagon receptor co-agonist, have been accepted for oral presentation at the European Association for the Study of the Liver Annual Congress from June 21-24.

June 12, 2023
·
5 min read
Drug Development

Allakos Presents Preclinical Data at EAACI Hybrid Congress 2023 Highlighting Lirentelimab and AK006 Mechanisms of Mast Cell Inhibition

Allakos Inc. announced an oral presentation at the European Academy of Allergy and Clinical Immunology Hybrid Congress 2023.

June 12, 2023
·
6 min read
PharmaTher Holdings Provides Corporate Update

PharmaTher Holdings Ltd., a commercial-focused specialty pharmaceutical company, provides a corporate update outlining the development and commercialization plans and upcoming milestones for its KETARX™ products and PharmaPatch™ delivery system.

June 12, 2023
·
7 min read